Overview
Venture capital firm investing in biotech and technology sectors.
Founded
2022
Deals ยท 12mo
9
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Onyx | Oct 2026Led | $8 MSeed | |
Enveda Biosciences | Sep 2026Participated | $311 MSeries E | |
Lanyon AI | Aug 2026Led | $11 MOther Equity | |
Chai Discovery | Jul 2026Participated | $400 MSeries C | |
Congruence Therapeutics | Mar 2026Led | $40 MOther Equity | |
Earendil Labs | Mar 2026Participated | $787 MOther Equity | |
Tamarind Bio | Mar 2026Led | $14 MSeries A | |
Automata | Jan 2026Led | $45 MSeries C | |
NewLimit | Oct 2025Participated | $45 MSeries B | |
Odyssey Therapeutics | Sep 2025Participated | $213 MSeries D | |
Fiveonefour | Sep 2025Led | $17 MOther Equity | |
Enveda Biosciences | Sep 2025Participated | $150 MSeries D | |
Onyx | Oct 2026Led | $8 MSeed | |
Enveda Biosciences | Sep 2026Participated | $311 MSeries E | |
Lanyon AI | Aug 2026Led | $11 MOther Equity | |
Chai Discovery | Jul 2026Participated | $400 MSeries C | |
Congruence Therapeutics | Mar 2026Led | $40 MOther Equity | |
Earendil Labs | Mar 2026Participated | $787 MOther Equity | |
Tamarind Bio | Mar 2026Led | $14 MSeries A | |
Automata | Jan 2026Led | $45 MSeries C | |
NewLimit | Oct 2025Participated | $45 MSeries B | |
Odyssey Therapeutics | Sep 2025Participated | $213 MSeries D | |
Fiveonefour | Sep 2025Led | $17 MOther Equity | |
Enveda Biosciences | Sep 2025Participated | $150 MSeries D |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 4 | 2 |
| Series A | 3 | 5 |
| Series B | 2 | 4 |
| Series C+ | 1 | 6 |
| Other Equity | 4 | 4 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Feb '21 | 1 |
| Mar '21 | 0 |
| Apr '21 | 0 |
| May '21 | 0 |
| Jun '21 | 0 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 0 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 1 |
| Jul '22 | 1 |
| Aug '22 | 0 |
| Sep '22 | 1 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 1 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 1 |
| May '23 | 1 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 1 |
| Oct '23 | 2 |
| Nov '23 | 1 |
| Dec '23 | 1 |
| Jan '24 | 1 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 2 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 2 |
| Sep '24 | 1 |
| Oct '24 | 0 |
| Nov '24 | 1 |
| Dec '24 | 0 |
| Jan '25 | 1 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 2 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 1 |
| Sep '25 | 3 |
| Oct '25 | 1 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 1 |
| Feb '26 | 0 |
| Mar '26 | 3 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 1 |
| Aug '26 | 1 |
| Sep '26 | 1 |
| Oct '26 | 1 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| AI & Machine Learning | 20 |
| Health & Life Sciences | 19 |
| Enterprise Software | 6 |
| Professional Services | 5 |
| Transportation & Logistics | 4 |
| Media & Entertainment | 3 |
| Data, Analytics & IT | 2 |
| Consumer & Lifestyle | 2 |
| Networks, Cloud & Communication | 2 |
| Hardware & Robotics | 2 |
| Manufacturing | 2 |
| Education & Workforce | 1 |
| Real Estate & Construction | 1 |
| Space & Frontier Tech | 1 |
| Food & Agriculture | 1 |
| Social & Community Platforms | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 4 |
| $5M-$10M | 6 |
| $10M-$25M | 6 |
| $25M-$50M | 7 |
| $50M-$100M | 4 |
| $100M-$250M | 5 |
| $250M-$500M | 2 |
| $500M-$1B | 1 |
| $1B+ | 0 |
Deals By Geography
Top 4 of 4 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 20 |
| Japan | 11 |
| Canada | 2 |
| Europe | 2 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| FPV Ventures | 5 |
| Kleiner Perkins | 5 |
| Lux Capital | 5 |
| Baillie Gifford | 4 |
| Kinnevik | 4 |
| True Ventures | 4 |
| Hummingbird Ventures | 3 |
| Premji Invest | 3 |
| SMBC Venture Capital | 3 |
| ANRI | 2 |
| Caffeinated Capital | 2 |
| Founders Fund | 2 |
| Human Capital | 2 |
| Jafco Ventures | 2 |
| Level Ventures | 2 |
| Lightspeed Venture Partners | 2 |
| Lingotto | 2 |
| Mitsubishi UFJ Capital | 2 |
| Mizuho Capital | 2 |
| Octopus Ventures | 2 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 14 | 40% |
| Participating | 21 | 60% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 9 | 64% |
| Co-led | 5 | 36% |